Investigation of specific protein/markers in patients with osteoarthritis of the knee having a total knee replacement
Study identifier:D2285M00029
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Investigation of Biomarkers in an Exploratory Study in Patients with Osteoarthritis of the Knee Undergoing Total Knee Replacement Surgery
Medical condition
Osteoarthritis of the knee
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
125
Study type
Observational
Age
40 Years +
Date
Study Start Date: 01 Dec 2011
Primary Completion Date: 01 Jun 2012
Study Completion Date: 01 Jun 2012
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Patients with osteoarthritis of the knee Patients with osteoarthritis of the knee undergoing total knee replacement surgery. | - |
Contacts
Investigators
Principal Investigator
Rolf Karlsten
AstraZeneca R&D Sodertalje, Sweden
